Radioligand Therapy: Seizing The Opportunity
Radioligand therapies (RLTs) are an emerging class of targeted therapies that are part of a growing trend of “precision medicine” treatments. The RLT market is expected to grow significantly over the course of this decade, driven by several clinical and commercial factors, with increasing interest in this modality from the academic, clinical and investor communities. Although there are a number of compelling growth drivers for the RLT market overall, there are also several challenges that will need to be overcome if the market is to achieve its full potential. Integration of RLTs into broad clinical practice will require careful consideration of several factors including manufacturing and supply chain, settings of care and the patient journey, as well as commercialization challenges.
Download '.pdf' Format of the whitepaper.
